AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31333199 — intervention group
Group type: EXPERIMENTAL
Intervention: Link intervention (Web-based mental health help-seeking navigation tool)
Number of subjects: 413
Study 28495410 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate reconstruction of the inferior alveolar nerve with a long processed nerve allograft (PNA) longer than 4.5 cm.
Number of subjects: 26
Study 28495410 — intervention group
Group type: COMPARATOR
Intervention: Positive control (no nerve repair).
Number of subjects: 26
Study 26817211 — intervention group
Group type: EXPERIMENTAL
Intervention: Feeding tube
Number of subjects: 120
Study 26817211 — intervention group
Group type: COMPARATOR
Intervention: Cup feeding
Number of subjects: 120
Study 23123199 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic walking group
Number of subjects: 65
Study 23123199 — intervention group
Group type: COMPARATOR
Intervention: Non-aerobic control group
Number of subjects: 65
Study 23123199 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-intervention VEGF levels
Number of subjects: 65
Study 21245953 — intervention group
Group type: EXPERIMENTAL
Intervention: C-T haplotype established by rs3793342 and rs11771443
Number of subjects: 190
Study 21245953 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (age- and sex-matched)
Number of subjects: 190
Study 18307592 — intervention group
Group type: EXPERIMENTAL
Intervention: RBV plus 1.5 microg/kg/week Peg‐IFN‐alpha2b
Number of subjects: 45
Study 18307592 — intervention group
Group type: EXPERIMENTAL
Intervention: RBV plus 1.0 microg/kg/week Peg‐IFN‐alpha2b
Number of subjects: 45
Study 18307592 — intervention group
Group type: COMPARATOR
Intervention: Early virological responders (EVR)
Number of subjects: 45
Study 18307592 — intervention group
Group type: COMPARATOR
Intervention: Rapid virological responders (RVR)
Number of subjects: 45
Study 16965639 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral addiction treatment with systematic reinforcement for goal attainment
Number of subjects: 95
Study 16965639 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral addiction treatment
Number of subjects: 95
Study 14633804 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g of cinnamon daily
Number of subjects: 60
Study 14633804 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g of cinnamon daily
Number of subjects: 60
Study 14633804 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 g of cinnamon daily
Number of subjects: 60
Study 14633804 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 10627108 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient treatment
Number of subjects: 1187
Study 10627108 — intervention group
Group type: EXPERIMENTAL
Intervention: Aftercare treatment
Number of subjects: 1187
Study 10627108 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist ratings in outpatient sample
Number of subjects: 1187
Study 10627108 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist ratings in aftercare sample
Number of subjects: 1187
Study 9113223 — intervention group
Group type: EXPERIMENTAL
Intervention: Restart program for men
Number of subjects: 1004
Study 9113223 — intervention group
Group type: COMPARATOR
Intervention: No Restart program for men
Number of subjects: 1004
Study 9113223 — intervention group
Group type: EXPERIMENTAL
Intervention: Restart program for women
Number of subjects: 1004
Study 9113223 — intervention group
Group type: COMPARATOR
Intervention: No Restart program for women
Number of subjects: 1004
Study 1586358 — intervention group
Group type: EXPERIMENTAL
Intervention: Pure exposure
Number of subjects: 48
Study 1586358 — intervention group
Group type: EXPERIMENTAL
Intervention: Interoceptive exposure
Number of subjects: 48
Study 1586358 — intervention group
Group type: EXPERIMENTAL
Intervention: Modification of negative cognitions
Number of subjects: 48
Study 1586358 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 48
Study 31847919 — intervention group
Group type: EXPERIMENTAL
Intervention: PEGASO system
Number of subjects: 525
Study 31847919 — intervention group
Group type: COMPARATOR
Intervention: Usual educational routine
Number of subjects: 525
Study 30227152 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin infiltration
Number of subjects: 42
Study 30227152 — intervention group
Group type: COMPARATOR
Intervention: Mock-infiltration (control)
Number of subjects: 42
Study 25452309 — intervention group
Group type: EXPERIMENTAL
Intervention: Diffusing capacity for carbon monoxide (DLCO)
Number of subjects: 300
Study 25452309 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced vital capacity (FVC)
Number of subjects: 300
Study 24506950 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-delivered cognitive behavioral therapy (CBT-T)
Number of subjects: 176
Study 24506950 — intervention group
Group type: COMPARATOR
Intervention: Nondirective supportive therapy (NST-T)
Number of subjects: 176
Study 22640439 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision aids (Statin Choice and Aspirin Choice, or Diabetes Medication Choice)
Number of subjects: 240
Study 22640439 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 240
Study 20678673 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil 23 mg/d
Number of subjects: 1467
Study 20678673 — intervention group
Group type: COMPARATOR
Intervention: Donepezil 10 mg/d
Number of subjects: 1467
Study 19055286 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage for supplementing qi and removing obstruction in the Governor Vessel
Number of subjects: 275
Study 19055286 — intervention group
Group type: COMPARATOR
Intervention: Routine massage therapy in Tuina Science (Control)
Number of subjects: 275
Study 16649966 — intervention group
Group type: EXPERIMENTAL
Intervention: B vitamins (5 mg of folic acid and 250 mg of pyridoxine)
Number of subjects: 151
Study 16649966 — intervention group
Group type: EXPERIMENTAL
Intervention: B vitamins (5 mg of folic acid)
Number of subjects: 151
Study 16649966 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151
Study 12839261 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.01% estradiol cream
Number of subjects: 65
Study 12839261 — intervention group
Group type: EXPERIMENTAL
Intervention: 15% glycolic acid cream
Number of subjects: 65
Study 12839261 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 0.01% estradiol and 15% glycolic acid creams
Number of subjects: 65
Study 12839261 — intervention group
Group type: COMPARATOR
Intervention: Vehicle cream
Number of subjects: 65
Study 10811761 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct cooling of the injured hand
Number of subjects: 10
Study 10811761 — intervention group
Group type: EXPERIMENTAL
Intervention: Body tilt
Number of subjects: 10
Study 10811761 — intervention group
Group type: COMPARATOR
Intervention: Healthy contralateral digits (control)
Number of subjects: 10
Study 8862047 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytopathologic assessment of cell type
Number of subjects: 116
Study 8862047 — intervention group
Group type: COMPARATOR
Intervention: Standard prognostic variables
Number of subjects: 116
Study 1635124 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal urethrotomy followed by clean intermittent self-catheterization for 3 months
Number of subjects: 61
Study 1635124 — intervention group
Group type: COMPARATOR
Intervention: Internal urethrotomy only (observation group)
Number of subjects: 61
Study 6720281 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin solution (1% watery solution, 1 drop, 4 times a day for 2 weeks)
Number of subjects: 74
Study 6720281 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin solution (local application during the first week post-surgery)
Number of subjects: 74
Study 6720281 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment with antibiotics and corticosteroid (from the third post-operative day)
Number of subjects: 74
Study 31582360 — intervention group
Group type: EXPERIMENTAL
Intervention: High-titre anti-influenza plasma (haemagglutination inhibition antibody titre ≥1:80)
Number of subjects: 200
Study 31582360 — intervention group
Group type: COMPARATOR
Intervention: Low-titre plasma (≤1:10)
Number of subjects: 200
Study 31582360 — intervention group
Group type: EXPERIMENTAL
Intervention: High-titre group
Number of subjects: 200
Study 31582360 — intervention group
Group type: COMPARATOR
Intervention: Low-titre group
Number of subjects: 200
Study 28811653 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% of daily energy consumed in the morning (BF group)
Number of subjects: 23
Study 28811653 — intervention group
Group type: COMPARATOR
Intervention: 50% of daily energy consumed in the evening (D group)
Number of subjects: 23
Study 26742068 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal protein (12 g) + normal fiber (2 g)
Number of subjects: 15
Study 26742068 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal protein (12 g) + high fiber (8 g)
Number of subjects: 15
Study 26742068 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein (25 g) + normal fiber (2 g)
Number of subjects: 15
Study 26742068 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein (25 g) + high fiber (8 g)
Number of subjects: 15
Study 26742068 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal protein (12 g)
Number of subjects: 15
Study 26742068 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein (25 g)
Number of subjects: 15
Study 26742068 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual food stimuli
Number of subjects: 15
Study 24958250 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic cigarette (medium-strength nicotine concentration 11 mg/ml for 7 minutes)
Number of subjects: 76
Study 24958250 — intervention group
Group type: COMPARATOR
Intervention: Regular cigarette (1 cigarette)
Number of subjects: 76
Study 22660375 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodyne NIR device
Number of subjects: 15
Study 22660375 — intervention group
Group type: EXPERIMENTAL
Intervention: HealthLight NIR device
Number of subjects: 15
Study 22660375 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 15
Study 20539854 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiovascular risk management package including education about risk factors and treatment with hydrochlorothiazide at 4 months for medium-risk patients.
Number of subjects: 2397
Study 20539854 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 2397
Study 17448569 — intervention group
Group type: EXPERIMENTAL
Intervention: Low glycemic-load diet
Number of subjects: 43
Study 17448569 — intervention group
Group type: COMPARATOR
Intervention: High glycemic-load diet
Number of subjects: 43
Study 15732857 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate (10 mg/day)
Number of subjects: 40
Study 15732857 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 12120884 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN‐alpha2a 9 million units 3x week for 6 months with HBV vaccine 20 microg given on 0, 1 and 2 months
Number of subjects: 29
Study 12120884 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN‐alpha2a 6 million units 3x week plus famciclovir 250 mg 3x day for 6 months
Number of subjects: 29
Study 12120884 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN‐alpha2a 6 million units 3x week plus lamivudine 100 mg/day for 6 months
Number of subjects: 29
Study 10710240 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen delivery (90 min daily at 2.2 Absolute Atmosphere for three cycles)
Number of subjects: 48
Study 10710240 — intervention group
Group type: COMPARATOR
Intervention: Control group (no hyperbaric oxygen delivery)
Number of subjects: 48
Study 8607307 — intervention group
Group type: EXPERIMENTAL
Intervention: Alkalinized 0.5% lignocaine (pH 7.2-7.3)
Number of subjects: 40
Study 8607307 — intervention group
Group type: COMPARATOR
Intervention: Normal 0.5% lignocaine (pH 5.2-5.3)
Number of subjects: 40
Study 8607307 — intervention group
Group type: EXPERIMENTAL
Intervention: Alkalinized 0.5% lignocaine
Number of subjects: 40
Study 8607307 — intervention group
Group type: COMPARATOR
Intervention: Normal 0.5% lignocaine
Number of subjects: 40
Study 2669648 — intervention group
Group type: EXPERIMENTAL
Intervention: PGI2‐A (300 micrograms/L)
Number of subjects: 45
Study 2669648 — intervention group
Group type: COMPARATOR
Intervention: Potassium cardioplegia (control)
Number of subjects: 45
Study 1033056 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg glisoxepide in the morning and 4 mg in the evening
Number of subjects: 11
Study 1033056 — intervention group
Group type: EXPERIMENTAL
Intervention: Tablets taken half-an-hour before breakfast
Number of subjects: 11
Study 1033056 — intervention group
Group type: EXPERIMENTAL
Intervention: Tablets taken one hour before breakfast
Number of subjects: 11
Study 1033056 — intervention group
Group type: COMPARATOR
Intervention: Standard diet
Number of subjects: 11
Study 30638840 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent calf compression low frequency (ICLF; 4 s on, 11 s off)
Number of subjects: 34
Study 30638840 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent calf compression high frequency (ICHF; 4 s on, 6 s off)
Number of subjects: 34
Study 30638840 — intervention group
Group type: COMPARATOR
Intervention: Static elastic compression stockings
Number of subjects: 34
Study 30638840 — intervention group
Group type: COMPARATOR
Intervention: Static inelastic compression stockings
Number of subjects: 34
Study 30638840 — intervention group
Group type: COMPARATOR
Intervention: Placebo condition
Number of subjects: 34
Study 30638840 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent calf compression at 0–60 mm Hg (ICLF)
Number of subjects: 34
Study 28427286 — intervention group
Group type: EXPERIMENTAL
Intervention: NAVIGATE, a coordinated specialty care program
Number of subjects: 399
Study 28427286 — intervention group
Group type: COMPARATOR
Intervention: Usual community care
Number of subjects: 399
Study 28427286 — intervention group
Group type: EXPERIMENTAL
Intervention: Obtaining SSA disability benefits
Number of subjects: 399
Study 24107979 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint protection
Number of subjects: 257
Study 24107979 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand exercises
Number of subjects: 257
Study 22189755 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive structured monitoring (ISM) group
Number of subjects: 1000
Study 22189755 — intervention group
Group type: COMPARATOR
Intervention: Active control (AC) group
Number of subjects: 1000
Study 22136024 — intervention group
Group type: EXPERIMENTAL
Intervention: Retained needling at Neiguan (PC 6) and Jianshi (PC 5) for 20 min
Number of subjects: 60
Study 22136024 — intervention group
Group type: COMPARATOR
Intervention: Non-retained needling at Neiguan (PC 6) and Jianshi (PC 5) for 20 min
Number of subjects: 60
Study 19321672 — intervention group
Group type: EXPERIMENTAL
Intervention: Urokinase
Number of subjects: 19
Study 19321672 — intervention group
Group type: COMPARATOR
Intervention: Saline solution
Number of subjects: 19
Study 16330055 — intervention group
Group type: EXPERIMENTAL
Intervention: Prism adaptation (PA) treatment for 10 daily sessions
Number of subjects: 16
Study 16330055 — intervention group
Group type: COMPARATOR
Intervention: General cognitive stimulation (control group)
Number of subjects: 16
Study 12974427 — intervention group
Group type: EXPERIMENTAL
Intervention: Streptokinase (2.5 lac units in 100 ml of normal saline instilled intrapleurally for 6 consecutive days)
Number of subjects: 24
Study 12974427 — intervention group
Group type: COMPARATOR
Intervention: Placebo (100 ml of normal saline instilled intrapleurally for 6 days)
Number of subjects: 24
Study 10917989 — intervention group
Group type: EXPERIMENTAL
Intervention: ICA occlusion (symptomatic or asymptomatic)
Number of subjects: 41
Study 10917989 — intervention group
Group type: EXPERIMENTAL
Intervention: ICA occlusion with atherosclerotic stenosis less than 75% of the contralateral ICA
Number of subjects: 41
Study 8868788 — intervention group
Group type: EXPERIMENTAL
Intervention: Femoral caliper intervention for controlling leg length during hip replacement
Number of subjects: 0
Study 8868788 — intervention group
Group type: COMPARATOR
Intervention: Standard hip replacement procedure without the femoral caliper
Number of subjects: 0
Study 1638588 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefaclor AF (375 mg twice daily)
Number of subjects: 563
Study 1638588 — intervention group
Group type: COMPARATOR
Intervention: Cefaclor (250 mg three times daily)
Number of subjects: 563
Study 1638588 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefaclor AF and Cefaclor
Number of subjects: 563
Study 6700601 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium carbonate
Number of subjects: 0
Study 6700601 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy without lithium carbonate
Number of subjects: 0
Study 30878226 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser peripheral iridotomy in treated eyes
Number of subjects: 889
Study 30878226 — intervention group
Group type: COMPARATOR
Intervention: Untreated eyes (control)
Number of subjects: 889
Study 30548118 — intervention group
Group type: EXPERIMENTAL
Intervention: M. officinalis capsules (700 mg/d)
Number of subjects: 62
Study 30548118 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 29798118 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug treatment and psychological intervention
Number of subjects: 60
Study 29798118 — intervention group
Group type: COMPARATOR
Intervention: Pure drug therapy (Control)
Number of subjects: 60
Study 25087210 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training, device training and home treatment (experimental group)
Number of subjects: 19
Study 25087210 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation treatment (control group)
Number of subjects: 19
Study 23731432 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative emotional material
Number of subjects: 2
Study 23731432 — intervention group
Group type: COMPARATOR
Intervention: Neutral material
Number of subjects: 2
Study 20734043 — intervention group
Group type: EXPERIMENTAL
Intervention: A‐SB group (anatomical single-bundle ACL reconstruction)
Number of subjects: 20
Study 20734043 — intervention group
Group type: COMPARATOR
Intervention: A‐DB group (anatomical double-bundle ACL reconstruction)
Number of subjects: 20
Study 18343353 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin (24 IU)
Number of subjects: 69
Study 18343353 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study 16809572 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin treatment
Number of subjects: 0
Study 16809572 — intervention group
Group type: EXPERIMENTAL
Intervention: Proinflammatory cytokines (interleukin‐1beta and interferon‐gamma)
Number of subjects: 0
Study 16809572 — intervention group
Group type: EXPERIMENTAL
Intervention: Geranylgeranyl transferase inhibitor, toxin B, C3 exoenzyme, Y‐27632
Number of subjects: 0
Study 16809572 — intervention group
Group type: COMPARATOR
Intervention: Control (no atorvastatin treatment)
Number of subjects: 0
Study 12623473 — intervention group
Group type: EXPERIMENTAL
Intervention: Active management of labour
Number of subjects: 448
Study 12623473 — intervention group
Group type: COMPARATOR
Intervention: Routine labour management
Number of subjects: 448
Study 11374209 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous oxygen therapy
Number of subjects: 4
Study 11374209 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen
Number of subjects: 4
Study 11374209 — intervention group
Group type: COMPARATOR
Intervention: Nocturnal oxygen
Number of subjects: 4
Study 11374209 — intervention group
Group type: COMPARATOR
Intervention: Long term oxygen
Number of subjects: 4
Study 9242853 — intervention group
Group type: EXPERIMENTAL
Intervention: Cups with larger handles
Number of subjects: 30
Study 9242853 — intervention group
Group type: COMPARATOR
Intervention: Cups with smaller handles
Number of subjects: 30
Study 8011570 — intervention group
Group type: COMPARATOR
Intervention: Atenolol 50 mg
Number of subjects: 27
Study 8011570 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol 50 mg and slow release nifedipine 20 mg twice a day
Number of subjects: 27
Study 2887542 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-adrenergic blockade (celiprolol, 600 mg)
Number of subjects: 9
Study 2887542 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium channel blockade (diltiazem, 30 or 60 mg four times daily)
Number of subjects: 9
Study 2887542 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 30982141 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand Massage (HM)
Number of subjects: 30
Study 30982141 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic Touch (TT)
Number of subjects: 30
Study 30982141 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 30
Study 29599391 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagenase clostridium histolyticum injection followed by limited fasciectomy in non-responsive cases
Number of subjects: 0
Study 29599391 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous needle fasciotomy followed by limited fasciectomy in non-responsive cases
Number of subjects: 0
Study 29599391 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary limited fasciectomy
Number of subjects: 0
Study 29599391 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 26914400 — intervention group
Group type: EXPERIMENTAL
Intervention: Early amniotomy
Number of subjects: 245
Study 26914400 — intervention group
Group type: COMPARATOR
Intervention: Repeat PGE2 vaginal gel
Number of subjects: 245
Study 25488560 — intervention group
Group type: EXPERIMENTAL
Intervention: Living ACTS educational intervention
Number of subjects: 268
Study 25488560 — intervention group
Group type: COMPARATOR
Intervention: Control video
Number of subjects: 268
Study 23123869 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower levels of adult activity in interaction at one year
Number of subjects: 180
Study 23123869 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower levels of adult speech in interaction at one year
Number of subjects: 180
Study 22000583 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose alcohol (1-2 mL)
Number of subjects: 76
Study 22000583 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose alcohol (>2 mL)
Number of subjects: 76
Study 22000583 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 76